logo
Select company
Select metric
-154.74%Free Cash Flow Margin
VS
Market
10
Sector
34
Industry
62
History
15
$ 1.23Close
$ 0.47 - $ 4.22 52-Week Range
Ticker Information

Ticker

NBY

Company Name

NOVABAY PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

NOVABAY PHARMACEUTICALS INC - Free Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NBY - FCF % Historical data
DateFree Cash FlowFree Cash Flow MarginRevenues
6/30/2025$ -7.35M-154.74%$ 4.75M
3/31/2025$ -4.94M-69.08%$ 7.15M
12/31/2024$ -5.19M-53.05%$ 9.78M
9/30/2024$ -4.53M-40.48%$ 11.2M
6/30/2024$ -2.83M-23.58%$ 12.02M
3/31/2024$ -4.1M-28.81%$ 14.23M
12/31/2023$ -4.15M-28.18%$ 14.73M
9/30/2023$ -5.04M-34.44%$ 14.64M
6/30/2023$ -6.45M-42.41%$ 15.2M
3/31/2023$ -6.31M-46.26%$ 13.64M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NOVABAY PHARMACEUTICALS INC's latest trailing twelve months (TTM) FCF % stands at -48.31%.
  • Over the past 5 years, NOVABAY PHARMACEUTICALS INC's average FCF % has been -63.62%.
  • The median FCF % for NOVABAY PHARMACEUTICALS INC during this period was -50.68%
  • NOVABAY PHARMACEUTICALS INC reached its highest FCF % over the past 5 years at -23.58%.
  • The lowest FCF % recorded by NOVABAY PHARMACEUTICALS INC in the same timeframe -154.74%

NOVABAY PHARMACEUTICALS INC's FCF % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

FCF % Benchmarks
CompanyFCF %
INM : INMED PHARMACEUTICALS INC -157.14%XBIO : XENETIC BIOSCIENCES INC -102.96%CNSP : CNS PHARMACEUTICALS INC -ENVB : ENVERIC BIOSCIENCES INC -CPHI : CHINA PHARMA HOLDINGS INC 8.1%GRI : GRI BIO INC -AZTR : AZITRA INC -ONCO : ONCONETIX INC -413%SPRB : SPRUCE BIOSCIENCES INC -3961.12%REVB : REVELATION BIOSCIENCES INC -

Definition of Free Cash Flow Margin

[Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
FCF / Revenues
(=) FCF %
FCF % for NOVABAY PHARMACEUTICALS INC is calculated as follows: FCF [ $ -4.71M ] / Revenues [ $ 9.75M ]
(=) FCF % [ -48.31% ]

NBY - Free Cash Flow Margin, Last 5 years

-154.74%

Minimum

Jun 30, 2025

-23.58%

Maximum

Jun 30, 2024

-63.62%

Average

-50.68%

Median

FCF % Benchmark Analysis

The chart above depicts the distribution of FCF % for companies in the Total Stock Market. The average FCF % of the companies is 7.87% with a standard deviation of 19.48%.
The following table provides additional summary stats:
FCF % in the Market:
filtered constituents3.18K
min-58.23%
max68.19%
average7.87%
median7.4%
std19.48%